Recurrent glioblastoma, sometimes referred to as glioblastoma multiforme or simplyGBM, stands as one of the most aggressive brain tumors known to medical science. Itis a malignancy that relentlessly invades the brain, presenting a formidable challengefor …
December 6, 2024
Leptomeningeal Metastases (LM) is sometimes referred to as leptomeningeal cancer,leptomeningeal disease, neoplastic meningitis, or meningeal carcinomatosis. This rarebut serious condition happens when cancer cells spread to the membranes surroundingthe brain and spinal cord. Leptomeningeal Metastases is …
December 6, 2024
Seizures and Brain Tumors Seizures are a common concern for many brain tumor patients due to changes in brain function. Seizures can result from the disruption of normal brain activity caused by brain tumors. Knowing …
November 18, 2024
The Karnofsky Performance Status (KPS) scale is a tool that helps doctors measure a person’s physical abilities, independence level, and how well a person can manage daily activities when dealing with a chronic illness, particularly …
November 18, 2024
Why Planning and Organization Matter After brain tumor treatment, changes in the brain can affect important thinking skills that help with planning, organizing, and starting tasks. These skills are necessary for managing day-to-day activities like …
November 18, 2024
Written by Erin Gaffney I’ve been fortunate to serve as an ambassador for several organizations. I joined the Executive Leadership Committee for the American Heart Association to raise awareness for heart disease. I participated in …
November 1, 2024
About Us Brain tumors present unique challenges, demanding specialized care from diagnosis through treatment. With a shared commitment to addressing these challenges, the Brain Cancer Support and Solutions Alliance leverages the strengths of its member organizations to …
September 18, 2024
Pediatric brain tumors are the most common type of solid childhood cancer and only second to leukemia as a cause of pediatric malignancies. The prognosis of pediatric brain tumors depends on the age at presentation, …
September 1, 2024
We are thrilled to announce the release of episode 13 of the Rare Enough Podcast, where we have the privilege of hosting Colin Gerner, the CEO and co-founder of StacheStrong. This episode is set to …
August 21, 2024
Meet actual users and caregivers at an Optune GioTM Open House! You’ll learn more about Optune Gio, an FDA-approved treatment for GBM. Optune Gio users and care partners will discuss their experiences living with GBM …
August 15, 2024
